Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus.

Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG.

Clin Cancer Res. 2006 Aug 1;12(15):4515-22.

2.

[Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].

Wang F, Xie XJ, Piao YS, Liu B, Wang LD.

Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):537-41. Chinese.

PMID:
22169643
3.

DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.

Zhang J, Martins CR, Fansler ZB, Roemer KL, Kincaid EA, Gustafson KS, Heitjan DF, Clark DP.

Clin Cancer Res. 2005 Sep 15;11(18):6544-9.

4.

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.

Clin Cancer Res. 2005 Aug 1;11(15):5365-9.

5.
6.

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.

Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA.

Mol Cancer. 2004 Oct 11;3:28.

7.

CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.

Gutiérrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, Bhatia K.

Mod Pathol. 2004 Oct;17(10):1268-74.

8.

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS.

Cancer Res. 2003 Nov 15;63(22):7563-70.

9.
10.

Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.

Pierini S, Jordanov SH, Mitkova AV, Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP, Goranova TE.

Head Neck. 2014 Aug;36(8):1103-8. doi: 10.1002/hed.23413. Epub 2013 Oct 7.

PMID:
23804521
11.

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.

Cancer Res. 2001 Jan 1;61(1):249-55.

12.

p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.

Roth MJ, Abnet CC, Hu N, Wang QH, Wei WQ, Green L, D'Alelio M, Qiao YL, Dawsey SM, Taylor PR, Woodson K.

Oncol Rep. 2006 Jun;15(6):1591-7.

PMID:
16685400
13.

DNA methylation profiles of lung tumors.

Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD, Gazdar AF.

Mol Cancer Ther. 2001 Nov;1(1):61-7.

14.

Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.

Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.

Int J Oncol. 2005 Jun;26(6):1493-500.

PMID:
15870861
15.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

16.

Promoter methylation profile in gallbladder cancer.

Roa JC, Anabalón L, Roa I, Melo A, Araya JC, Tapia O, de Aretxabala X, Muñoz S, Schneider B.

J Gastroenterol. 2006 Mar;41(3):269-75.

PMID:
16699861
17.

Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.

Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S, Nakao A.

Clin Cancer Res. 2001 Oct;7(10):3135-8.

18.

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM.

Br J Cancer. 2006 Feb 27;94(4):561-8.

19.

Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.

Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, Cai H, Washington K, Zheng W.

Oncol Rep. 2006 Aug;16(2):429-35.

PMID:
16820927
20.

Supplemental Content

Support Center